Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels.
Benatar
M
M
D000690:Amyotrophic Lateral Sclerosis / Q000276:immunology* / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D015220:Calcium Channels / Q000276:immunology*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans
D001323:Autoantibodies; D015220:Calcium Channels; D004298:Dopamine